WO2002030917A2 - Process for the production of racemic thioctic acid - Google Patents
Process for the production of racemic thioctic acid Download PDFInfo
- Publication number
- WO2002030917A2 WO2002030917A2 PCT/EP2001/011577 EP0111577W WO0230917A2 WO 2002030917 A2 WO2002030917 A2 WO 2002030917A2 EP 0111577 W EP0111577 W EP 0111577W WO 0230917 A2 WO0230917 A2 WO 0230917A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- process according
- group
- halo
- octanoic acid
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Definitions
- the present invention relates to a process of synthesis of racemic thioctic acid with phase transfer catalysis. STATE OF THE ART
- the state of the art describes processes of synthesis of racemic thioctic acid by reaction between sodium disuifide (Na 2 S 2 ), which is obtained in its turn from sulfur (S) and sodium sulfide (Na 2 S), and an alkyl ester of 6,8-dichlorooctanoic acid. Said processes are characterized by low yields (see J.A.C.S. Volume 79, 1957, page 6486). There was therefore the need to provide a process for the synthesis of racemic thioctic acid with high yield starting from the alkyl esters of 6,8- dichlorooctanoic acid.
- An object of the present invention is therefore a process of synthesis of racemic thioctic acid comprising the following stages: a) reaction of the alkyl ester of 6,8-di-halo-octanoic acid in an organic solvent with an aqueous solution of alkali disuifide in presence of a compound for phase transfer catalysis selected from the group consisting of quaternary ammonium or phosphonium salts having the following general formula:
- A is nitrogen of phosphorus
- R-i is selected from the group consisting of Cl, Br, I, HSO 4 and H 2 P0 4 , and the substituents R-i, R 2) R 3 and R 4 are selected from the group consisting of linear or branched alkyl radicals having one to twenty carbon atoms (d-
- the alkyl esters of 6,8-di-halo-octanoic acid are linear or branched C ⁇ -C 6 esters, and the halogen substituents, identical or different one from the other, are chosen from the group consisting of Cl, Br or I.
- the alkyl esters of 6,8-di-halo-octanoic acid are preferably linear or branched C-i- C 3 esters, and the halogen substituents, identical or different one from the other, are Cl or Br.
- the alkyl esters of 6,8-di-halo-octanoic acid are methyl ester br ethyl ester of 6,8-dichlorooctanoic acid.
- the amount of alkyl esters of 6,8-di-halo- octanoic acid in the reaction taking place in stage a) is between 5 and 60% by weight, preferably between 10 and 40% by weight, still more preferably between 15 and 30% by weight with respect to the organic solvent.
- the organic solvent used in the reaction taking place in stage a) is a solvent which cannot be mixed with water, selected from the group consisting of : linear or branched aliphatic C5-C10 hydrocarbons, or aromatic C 5 -C 10 hydrocarbons also having substituting groups selected from the group consisting of halogen, nitro or nitrile groups; esters of aliphatic or aromatic carboxylic acids; linear or cyclic ethers; linear or cyclic C4-C1 0 ketones, carbon disuifide, carbon tetrachloride.
- the solvent is preferably benzene or toluene.
- the process of synthesis of racemic thioctic acid according to present invention comprises the phase transfer of the disuifide ion from the aqueous solution containing the corresponding alkali disuifide to the organic phase which cannot be mixed with water, containing the alkyl ester of 6,8-di-halo-octanoic acid.
- the aqueous solution of alkali disuifide can be prepared by reacting in water sulfur (S) with the corresponding alkali sulfide.
- Preferred alkali disulfides are sodium disuifide (Na2S 2 ) and potassium disuifide (K 2 S 2 ) or their mixtures, still more preferred sodium disuifide.
- the molar ratio alkali disulfide/alkyl ester.of 6,,8-di-halo-octanoic acid is between 0.8 and 1.2, preferably between 0.9 and 1.1 , still more preferably between 0.95 and 1.0.
- the compounds for phase transfer catalysis used for the synthesis of thioctic acid which is the object of the present invention, are selected from the group consisting of tetrabutylammonium bromide, tetrabutylphosphonium bromide, methyltrioctylammonium chloride (ALIQUAT ® 336), methyl-(C ⁇ -C 10 )- trialkylammonium chloride (ADOGEN ® 464) and tetrabutylammonium hydrogensulfate; still more preferred are tetrabutylammonium bromide and tetrabutylammonium hydrogensulfate.
- a quaternary salt in the reaction taking place in stage a) the compound for phase transfer catalysis, is present in an amount between 0.5 to 10% in moles, preferably between 1 to 5% in moles, still more preferably between 2 to 4% in moles with respect to the alkyl ester of 6,8-di-halo-octanoic acid.
- the temperature of the reaction taking place in stage a) is between 20 and 130°C, preferably between 60 and 100°C, still more preferably between 80 and 90°C.
- Stage b), i.e. hydrolysis of the ester of racemic thioctic acid is a hydrolysis with alkali/alkaline-earth hydroxides in presence of organic solvents, such as alcohols and polyols, ethers and hydroxy ethers, ketones and hydroxy ketones, which can be mixed with water in a volume ratio of 50:50 to 95:5 at a temperature between 0 and 100°C.
- the concentration of the ester with respect to the organic solvent is between 5 and 50% w/v and the molar ratio ester/hydroxide is between 0.5 and 1.
- Free racemic thioctic acid can be recovered by treatment with aqueous mineral acids diluted 1 to 20% by weight or water-soluble organic acids.
- Reaction products and intermediate products are characterized with 1 H-NMR, Mass, HPLC analyses and potentiometric titration.
- the following area some examples disclosing though not limiting the present invention.
- Example 1- Synthesis of ethyl ester of racemic thioctic acid A mixture consisting of 16.91 g (0.13 moles) of sodium sulfide 60% by weight, 3.57 g (1.1 moles) of sulfur and 65 ml of water is heated at 85°C for 30 minutes. After being filtered to remove the insoluble portion, the solution is added in three hours to a solution consisting of 29.8 g (0.123 moles) of ethyl 6,8-dichlorooctanoate, 1.4 g (0.003 moles) of tetrabutylammonium bromide and 66 ml of toluene, kept at 82°C.
- the organic phase is concentrated by solvent evaporation under vacuum and the residue obtained is cooled down at 0-5°C for 8-10 hours.
- Said raw product is purified by dispersion under stirring in 6 ml of toluene and following crystallization from cyclohexane/ethyl acetate. 14.6 g of thioctic acid are obtained. The total yield is of 64%.
- the thioctic acid obtained is thus characterized: melting point: 60-62°C titer > 99% (HPLC, potentiometric titration) HPLC purity > 99%
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Description
Claims
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002534303A JP4257572B2 (en) | 2000-10-10 | 2001-10-08 | Method for producing racemic thioctic acid |
| EP01983530A EP1330449B1 (en) | 2000-10-10 | 2001-10-08 | Process for the production of racemic thioctic acid |
| AT01983530T ATE269319T1 (en) | 2000-10-10 | 2001-10-08 | METHOD FOR PRODUCING RACEMIC THIOCTIC ACID |
| US10/398,891 US6844450B2 (en) | 2000-10-10 | 2001-10-08 | Process for the production of a racemic thioctic acid |
| AU2002215012A AU2002215012A1 (en) | 2000-10-10 | 2001-10-08 | Process for the production of racemic thioctic acid |
| KR1020037004735A KR100822533B1 (en) | 2000-10-10 | 2001-10-08 | Method for producing racemic thioctic acid |
| DE60103923T DE60103923T2 (en) | 2000-10-10 | 2001-10-08 | PROCESS FOR THE PREPARATION OF RAZEMIC THIOCTIC ACID |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2000A002186 | 2000-10-10 | ||
| IT2000MI002186A IT1319194B1 (en) | 2000-10-10 | 2000-10-10 | RACEMO TIOTIC ACID PRODUCTION PROCESS. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2002030917A2 true WO2002030917A2 (en) | 2002-04-18 |
| WO2002030917A3 WO2002030917A3 (en) | 2002-07-25 |
Family
ID=11445935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2001/011577 Ceased WO2002030917A2 (en) | 2000-10-10 | 2001-10-08 | Process for the production of racemic thioctic acid |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6844450B2 (en) |
| EP (1) | EP1330449B1 (en) |
| JP (1) | JP4257572B2 (en) |
| KR (1) | KR100822533B1 (en) |
| AT (1) | ATE269319T1 (en) |
| AU (1) | AU2002215012A1 (en) |
| CZ (1) | CZ301711B6 (en) |
| DE (1) | DE60103923T2 (en) |
| ES (1) | ES2222399T3 (en) |
| IT (1) | IT1319194B1 (en) |
| WO (1) | WO2002030917A2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235582B2 (en) | 2003-04-22 | 2007-06-26 | Laboratorio Chimico Internazionale S.P.A. | Basic salt of thioctic acid with L-carnitine |
| WO2007138022A2 (en) | 2006-05-25 | 2007-12-06 | Eurand Pharmaceuticals Limited | Lipoic acid pellets |
| CN102558142A (en) * | 2010-12-23 | 2012-07-11 | 重庆药友制药有限责任公司 | Preparation method of alpha-lipoic acid bulk pharmaceutical |
| CN112574171A (en) * | 2020-12-15 | 2021-03-30 | 南京新百药业有限公司 | Preparation method of lipoic acid |
| CN116135849A (en) * | 2023-03-02 | 2023-05-19 | 厦门金达威维生素有限公司 | A kind of synthetic method of lipoic acid |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10137381A1 (en) * | 2001-07-31 | 2003-02-13 | Viatris Gmbh | New crystalline modifications of R-thioctic acid trometamol salt, useful as antiinflammatory agent, for treating diabetes mellitus or as appetite suppressant |
| DE10201464B4 (en) * | 2002-01-16 | 2005-06-16 | Viatris Gmbh & Co. Kg | Process for the preparation of pure thioctic acid |
| CN106349323B (en) * | 2016-08-25 | 2018-04-10 | 桂林益天成生物科技有限公司 | The method that hydrolysis asiatic centella total saponins prepare asiaticoside member |
| CN108774209A (en) * | 2018-08-03 | 2018-11-09 | 苏州富士莱医药股份有限公司 | A method of lipoic acid ethyl ester is prepared using tubular reactor |
| CN116969917B (en) * | 2023-05-30 | 2025-12-23 | 风火轮(上海)生物科技有限公司 | Method for synthesizing lipoic acid ester by utilizing buffer salt |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA608575A (en) * | 1960-11-15 | S. Acker Donald | Preparation of lipoic acid | |
| US2792406A (en) | 1954-06-01 | 1957-05-14 | Du Pont | Process of preparing alpha-lipoic acid using dichlorooctanoate and metal disulfide |
| DE3814163A1 (en) * | 1988-04-27 | 1989-11-09 | Rhein Chemie Rheinau Gmbh | METHOD FOR PRODUCING DISULFIDES |
| DE4342619A1 (en) * | 1993-12-14 | 1995-06-22 | Bayer Ag | Improved process for the preparation of 2,2'-dinitrodiphenyl disulfide |
| GB9510858D0 (en) | 1995-05-30 | 1995-07-26 | Chiroscience Ltd | Process for preparing lipoic acid |
| DE19533881A1 (en) * | 1995-09-13 | 1997-03-20 | Dresden Arzneimittel | Production and use of the pure enantiomers of 8-chloro-6-sulfonyloxy-octanoic acids and their alkyl esters and of the pure enantiomers of 6,8-dichloro-octanoic acid and their alkyl esters |
-
2000
- 2000-10-10 IT IT2000MI002186A patent/IT1319194B1/en active
-
2001
- 2001-10-08 AT AT01983530T patent/ATE269319T1/en not_active IP Right Cessation
- 2001-10-08 WO PCT/EP2001/011577 patent/WO2002030917A2/en not_active Ceased
- 2001-10-08 ES ES01983530T patent/ES2222399T3/en not_active Expired - Lifetime
- 2001-10-08 EP EP01983530A patent/EP1330449B1/en not_active Expired - Lifetime
- 2001-10-08 CZ CZ20031008A patent/CZ301711B6/en not_active IP Right Cessation
- 2001-10-08 US US10/398,891 patent/US6844450B2/en not_active Expired - Lifetime
- 2001-10-08 DE DE60103923T patent/DE60103923T2/en not_active Expired - Lifetime
- 2001-10-08 AU AU2002215012A patent/AU2002215012A1/en not_active Abandoned
- 2001-10-08 KR KR1020037004735A patent/KR100822533B1/en not_active Expired - Fee Related
- 2001-10-08 JP JP2002534303A patent/JP4257572B2/en not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235582B2 (en) | 2003-04-22 | 2007-06-26 | Laboratorio Chimico Internazionale S.P.A. | Basic salt of thioctic acid with L-carnitine |
| WO2007138022A2 (en) | 2006-05-25 | 2007-12-06 | Eurand Pharmaceuticals Limited | Lipoic acid pellets |
| CN102558142A (en) * | 2010-12-23 | 2012-07-11 | 重庆药友制药有限责任公司 | Preparation method of alpha-lipoic acid bulk pharmaceutical |
| CN112574171A (en) * | 2020-12-15 | 2021-03-30 | 南京新百药业有限公司 | Preparation method of lipoic acid |
| CN116135849A (en) * | 2023-03-02 | 2023-05-19 | 厦门金达威维生素有限公司 | A kind of synthetic method of lipoic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002215012A1 (en) | 2002-04-22 |
| ITMI20002186A0 (en) | 2000-10-10 |
| KR20030070002A (en) | 2003-08-27 |
| US6844450B2 (en) | 2005-01-18 |
| US20040030157A1 (en) | 2004-02-12 |
| CZ301711B6 (en) | 2010-06-02 |
| IT1319194B1 (en) | 2003-09-26 |
| WO2002030917A3 (en) | 2002-07-25 |
| ITMI20002186A1 (en) | 2002-04-10 |
| ATE269319T1 (en) | 2004-07-15 |
| EP1330449A2 (en) | 2003-07-30 |
| DE60103923T2 (en) | 2005-06-30 |
| DE60103923D1 (en) | 2004-07-22 |
| JP2004511475A (en) | 2004-04-15 |
| JP4257572B2 (en) | 2009-04-22 |
| EP1330449B1 (en) | 2004-06-16 |
| ES2222399T3 (en) | 2005-02-01 |
| KR100822533B1 (en) | 2008-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101771997B1 (en) | Method for producing a methylene disulfonate compound | |
| EP1330449B1 (en) | Process for the production of racemic thioctic acid | |
| EP1335911B1 (en) | Synthesis of r(+)alpha-lipoic acid | |
| JP5930930B2 (en) | Method for producing methylene disulfonyl chloride compound, methylene disulfonic acid compound and methylene disulfonate compound | |
| KR101056461B1 (en) | Manufacturing method of heterocyclic mercapto compound | |
| US5591859A (en) | Process for the production of 2-cyanoiminothiazolidine | |
| US4283339A (en) | Preparation of dioxane and co-products | |
| KR100477763B1 (en) | The Novel preparation of Intermediate of Cefatrizine Propylene gylcol | |
| US5206369A (en) | Process for the dehydration of dihydroxypiperidinedicarboxylates | |
| US4950784A (en) | Preparation of O-alkyl, S,S-dialkylphosphorodithioates | |
| JP7798472B2 (en) | Crystals of 9,9-bis(4-hydroxyphenyl)-2,3-benzofluorene | |
| KR920003898B1 (en) | Process for preparing 3,4-dehydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxy-1,1-deoxide | |
| JP3012933B1 (en) | Dithianaphthalenophane compound and method for producing the same | |
| JPS62195391A (en) | Manufacture of o-alkyl s,s-dialkylphosphorodithioate | |
| JPH0645616B2 (en) | Thiofenone derivative and method for producing the same | |
| JPS625911B2 (en) | ||
| JPH0463063B2 (en) | ||
| JP2007131557A (en) | Method for preparing triazine dithiol derivative | |
| HK1217689A1 (en) | Synthesis of calebin-a and its biologically active analogs | |
| HK1217689B (en) | Synthesis of calebin-a and its biologically active analogs | |
| KR20000017955A (en) | Process for preparing thiosalicylic acid | |
| JPS609756B2 (en) | Method for producing phthalidyl ester of aminobenzylpenicillanic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2002534303 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1020037004735 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10398891 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PV2003-1008 Country of ref document: CZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2001983530 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: PV2003-1008 Country of ref document: CZ |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001983530 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: 1020037004735 Country of ref document: KR |
|
| WWG | Wipo information: grant in national office |
Ref document number: 2001983530 Country of ref document: EP |

